These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 20635919

  • 1. Prevention of hepatitis B virus reactivation under rituximab therapy.
    Tsutsumi Y, Yamamoto Y, Tanaka J, Asaka M, Imamura M, Masauzi N.
    Immunotherapy; 2009 Nov; 1(6):1053-61. PubMed ID: 20635919
    [Abstract] [Full Text] [Related]

  • 2. Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin's lymphoma.
    Tsutsumi Y, Tanaka J, Kawamura T, Miura T, Kanamori H, Obara S, Asaka M, Imamura M, Masauzi N.
    Ann Hematol; 2004 Jan; 83(1):58-60. PubMed ID: 14513286
    [Abstract] [Full Text] [Related]

  • 3. Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis.
    Koo YX, Tay M, Teh YE, Teng D, Tan DS, Tan IB, Tai DW, Quek R, Tao M, Lim ST.
    Ann Hematol; 2011 Oct; 90(10):1219-23. PubMed ID: 21520001
    [Abstract] [Full Text] [Related]

  • 4. Reactivation of hepatitis B virus with rituximab.
    Tsutsumi Y, Kanamori H, Mori A, Tanaka J, Asaka M, Imamura M, Masauzi N.
    Expert Opin Drug Saf; 2005 May; 4(3):599-608. PubMed ID: 15934864
    [Abstract] [Full Text] [Related]

  • 5. Adherence to hepatitis B screening and prophylactic lamivudine for prevention of rituximab-associated hepatitis B reactivation.
    Liu CY, Chandrasekar PH, Masood A, Schiffer CA.
    J Oncol Pharm Pract; 2013 Mar; 19(1):18-23. PubMed ID: 22635416
    [Abstract] [Full Text] [Related]

  • 6. Reactivation of hepatitis virus B infection in a patient with rheumatoid arthritis after treatment with rituximab.
    Salman-Monte TC, Lisbona MP, García-Retortillo M, Maymó J.
    Reumatol Clin; 2014 Mar; 10(3):196-7. PubMed ID: 24054835
    [No Abstract] [Full Text] [Related]

  • 7. Hepatitis B virus reactivation in a case of non-Hodgkin's lymphoma treated with chemotherapy and rituximab: necessity of prophylaxis for hepatitis B virus reactivation in rituximab therapy.
    Tsutsumi Y, Kawamura T, Saitoh S, Yamada M, Obara S, Miura T, Kanamori H, Tanaka J, Asaka M, Imamura M, Masauzi N.
    Leuk Lymphoma; 2004 Mar; 45(3):627-9. PubMed ID: 15160930
    [Abstract] [Full Text] [Related]

  • 8. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
    Lan JL, Chen YM, Hsieh TY, Chen YH, Hsieh CW, Chen DY, Yang SS.
    Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis B virus reactivation with rituximab-containing regimen.
    Tsutsumi Y, Yamamoto Y, Shimono J, Ohhigashi H, Teshima T.
    World J Hepatol; 2013 Nov 27; 5(11):612-20. PubMed ID: 24303089
    [Abstract] [Full Text] [Related]

  • 10. Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: analysis from the Asia Lymphoma Study Group.
    Kim SJ, Hsu C, Song YQ, Tay K, Hong XN, Cao J, Kim JS, Eom HS, Lee JH, Zhu J, Chang KM, Reksodiputro AH, Tan D, Goh YT, Lee J, Intragumtornchai T, Chng WJ, Cheng AL, Lim ST, Suh C, Kwong YL, Kim WS.
    Eur J Cancer; 2013 Nov 27; 49(16):3486-96. PubMed ID: 23910494
    [Abstract] [Full Text] [Related]

  • 11. Reactivation of resolved hepatitis B during rituximab therapy for rheumatoid arthritis.
    Ghrénassia E, Mékinian A, Rouaghe S, Ganne N, Fain O.
    Joint Bone Spine; 2012 Jan 27; 79(1):100-1. PubMed ID: 21944979
    [No Abstract] [Full Text] [Related]

  • 12. Rituximab-induced hepatitis C virus reactivation in rheumatoid arthritis.
    Lin KM, Lin JC, Tseng WY, Cheng TT.
    J Microbiol Immunol Infect; 2013 Feb 27; 46(1):65-7. PubMed ID: 22627098
    [Abstract] [Full Text] [Related]

  • 13. Randomized controlled trial of entecavir prophylaxis for rituximab-associated hepatitis B virus reactivation in patients with lymphoma and resolved hepatitis B.
    Huang YH, Hsiao LT, Hong YC, Chiou TJ, Yu YB, Gau JP, Liu CY, Yang MH, Tzeng CH, Lee PC, Lin HC, Lee SD.
    J Clin Oncol; 2013 Aug 01; 31(22):2765-72. PubMed ID: 23775967
    [Abstract] [Full Text] [Related]

  • 14. Hepatitis B reactivation in patient with non-Hodgkin's lymphoma receiving rituximab-based chemotherapy: need for education and attention.
    Yang JD, Girotra M, Vaid A, Duarte-Rojo A.
    J Ark Med Soc; 2013 Nov 01; 110(6):110-2. PubMed ID: 24367885
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis B reactivation induced by Rituximab maintenance therapy for lymphoma.
    Cho CH, Hwang WL, Cheng SB, Lee TY, Teng CL.
    Ann Hematol; 2011 Jan 01; 90(1):111-2. PubMed ID: 20407894
    [No Abstract] [Full Text] [Related]

  • 16. Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations.
    Picardi M, Pane F, Quintarelli C, De Renzo A, Del Giudice A, De Divitiis B, Persico M, Ciancia R, Salvatore F, Rotoli B.
    Haematologica; 2003 Nov 01; 88(11):1296-303. PubMed ID: 14607759
    [Abstract] [Full Text] [Related]

  • 17. Analysis of hepatitis B surface antibody titers in B cell lymphoma patients after rituximab therapy.
    Pei SN, Ma MC, Wang MC, Kuo CY, Rau KM, Su CY, Chen CH.
    Ann Hematol; 2012 Jul 01; 91(7):1007-12. PubMed ID: 22273839
    [Abstract] [Full Text] [Related]

  • 18. Very late onset hepatitis-B virus reactivation following rituximab despite lamivudine prophylaxis: the need for continued vigilance.
    Chew E, Thursky K, Seymour JF.
    Leuk Lymphoma; 2014 Apr 01; 55(4):938-9. PubMed ID: 23772645
    [No Abstract] [Full Text] [Related]

  • 19. Reactivation of lamivudine-resistant occult hepatitis B in an HIV-infected patient undergoing cytotoxic chemotherapy.
    Schnepf N, Sellier P, Bendenoun M, Zini JM, Sanson-le Pors MJ, Mazeron MC.
    J Clin Virol; 2007 May 01; 39(1):48-50. PubMed ID: 17368969
    [Abstract] [Full Text] [Related]

  • 20. Prospective analysis of hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma after rituximab combination chemotherapy.
    Niitsu N, Hagiwara Y, Tanae K, Kohri M, Takahashi N.
    J Clin Oncol; 2010 Dec 01; 28(34):5097-100. PubMed ID: 20837949
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.